The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2024 | Advancements in stent technology for treating central airway obstruction
Ricky Thakrar, MBBs, PhD IBSc, University College London Hospitals NHS Foundation Trust, London, UK, discusses advancements in stent technology for treating central airway obstruction. A significant challenge with stents is that all patients typically experience some form of complication, most commonly mucus stasis, where secretions become trapped in the stent, necessitating repeat bronchoscopies. Innovations include stents impregnated with radioactive beads and other drugs to combat granulation tissue. These advancements hold promise for improved management of central airway obstruction in the future. This interview took place at the BTOG 2024 congress in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
